Patents by Inventor Omar TOUZANI

Omar TOUZANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11446626
    Abstract: The present invention relates to a method for the preparation of a colloidal aqueous suspension of stable zeolite nanocrystals having framework structures comprising at least one cation selected from Gd, Fe, Cu and Ce, said structures being loaded with a gas selected from O2, CO2 and mixtures thereof, to the colloidal aqueous suspension of zeolite nanocrystals obtained by such a process, and to the use of said suspension in therapy, more particularly in cancer therapy and hypoxia-related diseases and/or in diagnosis.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: September 20, 2022
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE CAEN NORMANDIE
    Inventors: Samuel Valable, Svetlana Mintova Lazarova, Clément Anfray, Valentin Valtchev, Omar Touzani, Myriam Bernaudin
  • Publication number: 20220152089
    Abstract: The present invention relates to a pharmaceutical composition for its application as a drug, in particular for use in the protection of the blood-brain barrier and/or the repair and/or the restoration of the blood brain barrier. The present invention finds an application in particular in the therapeutic, pharmaceutical and veterinary fields.
    Type: Application
    Filed: April 30, 2020
    Publication date: May 19, 2022
    Inventors: Denis BARRITAULT, Myriam BERNAUDIN, Omar TOUZANI, Jérôme TOUTAIN, Yacine KHELIF
  • Publication number: 20200238242
    Abstract: The present invention relates to a method for the preparation of a colloidal aqueous suspension of stable zeolite nanocrystals having framework structures comprising at least one cation selected from Gd, Fe, Cu and Ce, said structures being loaded with a gas selected from O2, CO2 and mixtures thereof, to the colloidal aqueous suspension of zeolite nanocrystals obtained by such a process, and to the use of said suspension in therapy, more particularly in cancer therapy and hypoxia-related diseases and/or in diagnosis.
    Type: Application
    Filed: August 7, 2018
    Publication date: July 30, 2020
    Inventors: Samuel VALABLE, Svetlana MINTOVA LAZAROVA, Clément ANFRAY, Valentin VALTCHEV, Omar TOUZANI, Myriam BERNAUDIN
  • Publication number: 20180161372
    Abstract: Some embodiments are directed to a pharmaceutical composition which includes a biocompatible polymer and a eukaryotic cell to be used as a drug for the prevention and/or treatment of tissue lesions of the central nervous system caused by cerebral vascular ischaemia. Some embodiments are also directed to a pharmaceutical kit which includes a biocompatible polymer and a eukaryotic cell for the prevention and/or treatment of tissue lesions of the central nervous system caused by cerebral vascular ischaemia. Some other embodiments can be used in particular in the human and veterinary pharmaceutical fields.
    Type: Application
    Filed: May 26, 2016
    Publication date: June 14, 2018
    Inventors: Myriam BERNAUDIN, Omar TOUZANI, Jérôme TOUTAIN, Marie-Sophie QUITTET, Denis BARRITAULT